Chapter

Vaccines

Max V. Kuenstling, Eric J. Benner and R. Lee Mosley

in The Neurology of AIDS

Third edition

Published on behalf of Oxford University Press

Published in print December 2011 | ISBN: 9780195399349
Published online September 2012 | e-ISBN: 9780199965199 | DOI: http://dx.doi.org/10.1093/med/9780195399349.003.0010
Vaccines

More Like This

Show all results sharing these subjects:

  • Disorders of the Nervous System
  • Infectious Diseases

GO

Show Summary Details

Preview

The ultimate goal of vaccination is to deliver effective immunity that, under conditions of disease exposure, either prevents infection or allows rapid clearance of infected cells. However, developing an effective vaccine for HIV-1 is fraught with difficulties. A major challenge is the speed with which HIV-1 incorporates its genomic information into host DNA in the form of a relatively inaccessible latent provirus. Other challenges include the (to date) inability of vaccines to elicit adequate neutralizing antibodies in humans; difficulties in finding adequate small-animal models for vaccine research; and the threat that an otherwise-effective vaccine would, by stimulating an immune response in the brain, itself exacerbate the inflammatory activation that appears to play a central role in the neuropathogenesis of HIV-1 infection. This chapter aims to provide an understanding of the challenges that have impeded the development of a successful HIV vaccine, and to describe some potentially effective strategies that may ultimately provide at least some clinically important level of vaccine protection. As part of the presentation, the results of clinical vaccine trials are discussed.

Chapter.  23355 words. 

Subjects: Disorders of the Nervous System ; Infectious Diseases

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.